Breaking News Instant updates and real-time market news.

NAVB

Navidea

$0.80

0.0359 (4.67%)

, CAH

Cardinal Health

$70.55

0.42 (0.60%)

17:44
11/23/16
11/23
17:44
11/23/16
17:44

On The Fly: After Hours Movers

HIGHER: Navidea (NAVB), up 25.5%, extending gains after hours following its asset purchase agreement with Cardinal Health (CAH)... Insteel (IIIN), up 5.5% after it was named to replace Littlefuse (LFUS) in the S&P 600. LOWER: Corbus Pharmaceuticals (CRBP), down 6.3% after entering a controlled equity offering sales agreement with Cantor Fitzgerald... Airgain (AIRG), down 5% after it announced the release of lock up restrictions on common stock.

NAVB

Navidea

$0.80

0.0359 (4.67%)

CAH

Cardinal Health

$70.55

0.42 (0.60%)

IIIN

Insteel

$36.58

0.76 (2.12%)

LFUS

Littelfuse

$149.72

2.81 (1.91%)

CRBP

Corbus Pharmaceuticals

$8.00

0.05 (0.63%)

AIRG

Airgain

$26.95

0.2 (0.75%)

  • 28

    Nov

  • 29

    Nov

  • 29

    Nov

  • 07

    Dec

  • 09

    Dec

NAVB Navidea
$0.80

0.0359 (4.67%)

CAH Cardinal Health
$70.55

0.42 (0.60%)

10/28/16
BARD
10/28/16
DOWNGRADE
BARD
Neutral
Cardinal Health downgraded to Neutral from Outperform at Baird
10/28/16
BARD
10/28/16
DOWNGRADE
Target $82
BARD
Neutral
Cardinal Health downgraded to Neutral at Baird
As reported previously, Baird analyst David Coldwell downgraded Cardinal Health (CAH) to Neutral from Outperform as aggressive competition is trying to recapture pharmacy share and the company will have to defend its pharmacy base. Coldwell lowered his price target to $82 from $92 on Cardinal Health shares, which are down over 6% to $70 in pre-market trading following a downbeat quarterly report and cautious guidance last night from peer McKesson (MCK).
10/10/16
CLVD
10/10/16
DOWNGRADE
CLVD
Neutral
Cardinal Health downgraded to Neutral from Buy at Cleveland Research
10/05/16
UBSW
10/05/16
INITIATION
Target $82
UBSW
Neutral
Cardinal Health initiated with a Neutral at UBS
Target $82.
IIIN Insteel
$36.58

0.76 (2.12%)

04/01/16
SIDC
04/01/16
DOWNGRADE
SIDC
Neutral
Insteel downgraded to Neutral from Buy at Sidoti
Sidoti downgraded Insteel to Neutral citing a PC strand capacity increase from a competitor and maintained its $32 price target on shares.
11/22/16
SIDC
11/22/16
UPGRADE
Target $44
SIDC
Buy
Insteel upgraded to Buy from Neutral at Sidoti
Sidoti upgraded Insteel to Buy and raised its price target to $44 from $32 siting increased wire rod prices.
LFUS Littelfuse
$149.72

2.81 (1.91%)

11/21/16
SIDC
11/21/16
DOWNGRADE
Target $157
SIDC
Neutral
Littelfuse downgraded to Neutral from Buy at Sidoti
Sidoti downgraded Littelfuse to Neutral citing the recent rise in shares and maintained its $157 price target.
09/08/16
BARD
09/08/16
NO CHANGE
Target $132
BARD
Outperform
Littelfuse investors should be aggressive on pullbacks, says Baird
Baird analyst Timothy Wojs met with Littlefuse management and came away more confident that shares should be bought aggressively on any pullbacks. The analyst continues to like the long-term risk/reward given the company's relatively solid organic growth and execution as well as recent M&A activity, which had provided some upside bias to numbers over time. Wojs reiterated his Outperform rating and $132 price target on Littlefuse shares.
09/13/16
OPCO
09/13/16
NO CHANGE
Target $145
OPCO
Outperform
Littelfuse price target raised to $145 from $138 at Oppenheimer
Oppenheimer analyst Christopher Glynn raised his price target for Littelfuse to $145 from $138, citing liquidity, acquisition track record, and underlying earnings power runway on portfolio integration. The analyst continues to view shares of Littelfuse as his top pick for strategy deployment and compounding runway over the next several years. He reiterates an Outperform rating on the shares.
10/28/16
OPCO
10/28/16
NO CHANGE
Target $155
OPCO
Outperform
Littelfuse price target raised to $155 from $145 at Oppenheimer
Oppenheimer analyst Christopher Glynn raised his price target for Littelfuse to $155 from $145 after the company raised its Q3 guidance. The analyst reiterates an Outperform rating on the shares.
CRBP Corbus Pharmaceuticals
$8.00

0.05 (0.63%)

10/04/16
CANT
10/04/16
INITIATION
Target $17
CANT
Buy
Corbus Pharmaceuticals initiated with a Buy at Cantor
Cantor initiated Corbus Pharmaceuticals with a Buy and a $17 price target.
11/15/16
JMPS
11/15/16
NO CHANGE
JMPS
Corbus Pharmaceuticals price target raised to $20 from $9 at JMP Securities
JMP Securities analyst Liisa Bayko raised her price target on Corbus as she believes that data on the company's Resunab drug for scleroderma indicates that its efficacy could be significantly positive, while its safety/tolerability could be "favorable." Bayko keeps an Outperform rating on the shares.
09/19/16
AGIS
09/19/16
NO CHANGE
Target $12
AGIS
Buy
Corbus Pharmaceuticals price target raised to $12 from $7 at Aegis
Aegis analyst Robert Leboyer raised his price target for Corbus Pharmaceuticals to $12 from $7 and keeps a Buy rating on the name.
10/25/16
NBLE
10/25/16
NO CHANGE
NBLE
Corbus Pharmaceuticals risk/reward remains favorable, says Noble Financial
Noble Financial analyst Kumaraguru Raja remains bullish on Corbus' Resunab being developed for treating inflammation and fibrosis as it preferentially targets CB2 receptor; saying preliminary positive data in healthy volunteers validates role in inflammation resolution. The analyst said Resunab has better anti-inflammatory activity even in low doses adn the open-label extension indicates the FDA comfort with safety and efficacy. Raja likes Corbus' risk/reward heading into multiple data readouts and reiterates his Buy rating and $19 price target on shares.
AIRG Airgain
$26.95

0.2 (0.75%)

09/21/16
WDLK
09/21/16
DOWNGRADE
Target $14
WDLK
Hold
Airgain downgraded to Hold from Buy at Wunderlich
Wunderlich analyst Matthew Robison downgraded Airgain to Hold with a $14 price target following the company's Q2 results.
10/31/16
WDLK
10/31/16
UPGRADE
WDLK
Buy
Airgain upgraded to Buy from Hold at Wunderlich
Wunderlich analyst Matthew Robison upgraded Airgain to Buy.
10/31/16
WDLK
10/31/16
UPGRADE
Target $16
WDLK
Buy
Airgain upgraded to Buy on recent pullback at Wunderlich
Wunderlich analyst Matthew Robison upgraded Airgain to Buy from Hold saying the recent pullback in shares has created an attractive entry point. The company's business continues to progress, Robison tells investors in a research note. He raised his price target for the shares to $16 from $14.
09/06/16
NORL
09/06/16
INITIATION
Target $15
NORL
Outperform
Airgain initiated with an Outperform at Northland
Northland analyst Tom Sepenzis initiated Airgain with an Outperform rating and $15 price target.

TODAY'S FREE FLY STORIES

PAAS

Pan American Silver

$15.20

0.22 (1.47%)

05:42
11/22/17
11/22
05:42
11/22/17
05:42
Upgrade
Pan American Silver rating change  »

Pan American Silver…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 05

    Dec

CBRL

Cracker Barrel

$150.79

-6.41 (-4.08%)

05:41
11/22/17
11/22
05:41
11/22/17
05:41
Downgrade
Cracker Barrel rating change  »

Cracker Barrel downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIPS

Vipshop

$8.22

-1.03 (-11.14%)

05:39
11/22/17
11/22
05:39
11/22/17
05:39
Recommendations
Vipshop analyst commentary  »

Vipshop price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NJR

New Jersey Resources

$43.80

-0.5 (-1.13%)

05:35
11/22/17
11/22
05:35
11/22/17
05:35
Upgrade
New Jersey Resources rating change  »

New Jersey Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBPB

Potbelly

$12.15

-0.15 (-1.22%)

05:31
11/22/17
11/22
05:31
11/22/17
05:31
Recommendations
Potbelly analyst commentary  »

Potbelly shares remain…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRM

Salesforce

$108.80

1.43 (1.33%)

05:29
11/22/17
11/22
05:29
11/22/17
05:29
Recommendations
Salesforce analyst commentary  »

Salesforce price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

YNDX

Yandex

$34.28

0.57 (1.69%)

05:28
11/22/17
11/22
05:28
11/22/17
05:28
Hot Stocks
Yandex appoints Greg Abovsky as COO »

Yandex announced changes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNK

Mallinckrodt

$21.39

-0.42 (-1.93%)

05:26
11/22/17
11/22
05:26
11/22/17
05:26
Downgrade
Mallinckrodt rating change  »

Mallinckrodt downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

05:25
11/22/17
11/22
05:25
11/22/17
05:25
General news
FX Action: The dollar has perked up »

FX Action: The dollar…

SIG

Signet Jewelers

$52.79

-23.05 (-30.39%)

05:22
11/22/17
11/22
05:22
11/22/17
05:22
Recommendations
Signet Jewelers analyst commentary  »

Signet Jewelers price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

AXTA

Axalta Coating

$33.87

0.33 (0.98%)

05:19
11/22/17
11/22
05:19
11/22/17
05:19
Recommendations
Axalta Coating analyst commentary  »

Nippon could bid as much…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXTA

Axalta Coating

$33.87

0.33 (0.98%)

, AKZOY

AkzoNobel

$30.57

0.085 (0.28%)

05:16
11/22/17
11/22
05:16
11/22/17
05:16
Hot Stocks
Axalta Coating confirms takeover talks with Nippon Paint »

Axalta Coating Systems…

AXTA

Axalta Coating

$33.87

0.33 (0.98%)

AKZOY

AkzoNobel

$30.57

0.085 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RLOG

Rand Logistics

$0.59

0.016 (2.80%)

05:15
11/22/17
11/22
05:15
11/22/17
05:15
Hot Stocks
Rand Logistics to be acquired by American Industrial Partners »

Rand Logistics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGMS

Scientific Games

$52.20

-0.3 (-0.57%)

05:12
11/22/17
11/22
05:12
11/22/17
05:12
Hot Stocks
Scientific Games acquires 11.6M ordinary shares of NYX Gaming »

Scientific Games…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADI

Analog Devices

$90.19

-2.88 (-3.09%)

05:12
11/22/17
11/22
05:12
11/22/17
05:12
Recommendations
Analog Devices analyst commentary  »

Analog Devices price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

TEDU

Tarena

$13.36

-2.53 (-15.92%)

05:10
11/22/17
11/22
05:10
11/22/17
05:10
Downgrade
Tarena rating change  »

Tarena downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPQ

HP Inc.

$22.46

0.34 (1.54%)

05:07
11/22/17
11/22
05:07
11/22/17
05:07
Recommendations
HP Inc. analyst commentary  »

HP Inc. target raised to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRM

Salesforce

$108.80

1.43 (1.33%)

05:05
11/22/17
11/22
05:05
11/22/17
05:05
Recommendations
Salesforce analyst commentary  »

Salesforce price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

AXTA

Axalta Coating

$33.87

0.33 (0.98%)

, AKZOY

AkzoNobel

$30.57

0.085 (0.28%)

05:03
11/22/17
11/22
05:03
11/22/17
05:03
Recommendations
Axalta Coating, AkzoNobel, Berkshire Hathaway, Berkshire Hathaway analyst commentary  »

Axalta remains potential…

AXTA

Axalta Coating

$33.87

0.33 (0.98%)

AKZOY

AkzoNobel

$30.57

0.085 (0.28%)

BRK.A

Berkshire Hathaway

$275,000.00

2995 (1.10%)

BRK.B

Berkshire Hathaway

$183.18

1.55 (0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRM

Salesforce

$108.80

1.43 (1.33%)

04:57
11/22/17
11/22
04:57
11/22/17
04:57
Recommendations
Salesforce analyst commentary  »

Salesforce positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

04:55
11/22/17
11/22
04:55
11/22/17
04:55
General news
Breaking General news story  »

Week of 11/17 MBA…

04:55
11/22/17
11/22
04:55
11/22/17
04:55
General news
Jobless Claims to be reported at 08:30 »

Week of 11/18 Jobless…

04:55
11/22/17
11/22
04:55
11/22/17
04:55
General news
Breaking General news story  »

Week of 11/19 Bloomberg…

MKSI

MKS Instruments

$105.15

-0.35 (-0.33%)

, BRCD

Brocade

04:55
11/22/17
11/22
04:55
11/22/17
04:55
Hot Stocks
MKS Instruments to replace Brocade in S&P 400 at open on 11/22 »

S&P 500 constituent…

MKSI

MKS Instruments

$105.15

-0.35 (-0.33%)

BRCD

Brocade

AVGO

Broadcom

$276.59

1.71 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

IVR

Invesco Mortgage

$18.13

0.11 (0.61%)

, MKSI

MKS Instruments

$105.15

-0.35 (-0.33%)

04:55
11/22/17
11/22
04:55
11/22/17
04:55
Hot Stocks
Breaking Hot Stocks news story on Invesco Mortgage, MKS Instruments »

Invesco Mortgage to…

IVR

Invesco Mortgage

$18.13

0.11 (0.61%)

MKSI

MKS Instruments

$105.15

-0.35 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.